• BREAKING NEWS ABC shows live and on-demand -- Download the WATCH ABC app!

New weight loss pill awaiting FDA approval

A weight loss pill called Qnexa is awaiting FDA approval. A study showed that it resulted in twice as much weight loss.

April 11, 2011 12:00:00 AM PDT
An experimental weight loss pill is awaiting FDA approval.

Experts said the drug shows promise. The treatment called Qnexa combines the migraine drug Topomax and the weight loss drug Phentermine.

A study shows that when combined Qnexa it resulted in twice as much weight loss as the only approved long term anti-obesity medication.

Researchers said the drug also appeared to reduce other obesity related indicators like blood pressure and cholesterol. The study was paid for by the pharmaceutical company that makes Qnexa.

Load Comments